Essex Bio-Technology Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Essex Bio-Technology Limited with three other
pharmaceutical manufacturers in Asia:
of South Korea
sales of 88.51 billion Korean Won [US$75.32 million]
of which 100%
Jiangxi Boya Bio-Pharmaceutical Co Ltd
(543.10 million Chinese Renmimbi [US$78.98 million]
of which 63%
was Blood Plasma), and
Samsung Biologics Co Ltd
based in South Korea
(91.28 billion Korean Won [US$77.68 million]
Essex Bio-Technology Limited reported sales of HK$654.01 million (US$84.32 million)
December of 2015.
increase of 26.2%
versus 2014, when the company's sales were HK$518.30 million.
Sales at Essex Bio-Technology Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 347%).
Sales of Other Businesses saw an increase
that was more than double the company's growth rate: sales were up
72.3% in 2015, from
HK$29.71 million to HK$51.17 million.